Recall Z-1133-2019— BioFire Diagnostics, LLC

Class II · Terminated

Class II FDA medical device recall by BioFire Diagnostics, LLC, initiated 2019-03-07, terminated 2022-08-24. It names 4 FDA 510(k) clearances: K181493, K160457, K143171 and 1 more. Product: FilmArray BCID Panel, IVD, Rx Only, BioFire Diagnostics, REF: RFIT-ASY-0126, and RFIT-ASY-0127, when used with the following blood culture bottles: Bottle Description/Part Number: BACT/ALERT FA Plus/410851; BACT/ALERT FN Plus/410852; BACT/ALERT PF Plus/410853. Reason: Increased risk of false positive Enterobacteriaceae and Escherichia coli results on affected blood culture identification panels when using certain blood culture bottles..

Recalling firm
BioFire Diagnostics, LLC
Classification
Class II
Status
Terminated
Initiated
2019-03-07
Terminated
2022-08-24
Firm location
Salt Lake City, UT, United States

510(k) clearances named in this recall

4 on FDA's record

K-numbers as listed on FDA's Recall Enterprise System record for this event (openFDA device/recall k_numbers). The recall may also cover devices cleared under other submissions not named here.

Product description

FilmArray BCID Panel, IVD, Rx Only, BioFire Diagnostics, REF: RFIT-ASY-0126, and RFIT-ASY-0127, when used with the following blood culture bottles: Bottle Description/Part Number: BACT/ALERT FA Plus/410851; BACT/ALERT FN Plus/410852; BACT/ALERT PF Plus/410853

Reason for recall

Increased risk of false positive Enterobacteriaceae and Escherichia coli results on affected blood culture identification panels when using certain blood culture bottles.

Data sourced from openFDA. This site is unofficial and independent of the FDA.